What Does the Research Actually Say About Nicotine-Free Pouch Ingredients?
A review of the published evidence behind the three most common approaches to replacing nicotine in an oral pouch: caffeine, caffeine's primary metabolite, and functional mushrooms.
The nicotine-free pouch category has grown quickly, and so has the range of ingredients used to replace nicotine's stimulation. Most of that growth has outpaced the research base behind any single formula.
This isn't a review of marketing claims. It's a review of what the underlying human research shows for each ingredient category currently used across the market, evaluated on its own terms.
SCOPE OF THIS REVIEW.
CAFFEINE
PARAXANTHINE
FUNCTIONAL MUSHROOMS
Three stimulant categories, three different evidence bases. Each is reviewed independently below.
CATEGORY 1
Category 1: Caffeine
Caffeine is the most-studied stimulant in this category by a wide margin, with decades of human research behind its acute effects on alertness and cognitive performance. It's also the most predictable in its downsides: dose-dependent jitteriness, tolerance with regular use, and a well-documented crash as blood levels decline.
Caffeine's research base is not in question. What's relevant here is simpler: a caffeine pouch is a caffeine delivery product. The stimulant profile is nicotine's, replaced with a different, well-characterized stimulant.
STUDY CONTEXT: CAFFEINE.
Caffeine's acute effects on alertness and cognitive performance are well established in the research literature. Its side effect profile, including jitteriness, tolerance, and rebound fatigue, is equally well documented.
CATEGORY 2
Category 2: Paraxanthine
Paraxanthine is caffeine's primary liver metabolite, produced when the CYP1A2 enzyme breaks caffeine down. Roughly 84 percent of ingested caffeine converts to paraxanthine in the body.1 Because it occurs naturally as a byproduct of caffeine metabolism, some formulations use it directly, positioning it as a "caffeine-free" alternative on the theory that it produces similar alertness with a shorter half-life.
The research on paraxanthine specifically, separate from caffeine, is newer and considerably smaller than caffeine's own literature. Early data suggests a faster clearance time compared with caffeine, but the ingredient is still, mechanistically, part of the same stimulant pathway.1
STUDY CARD: PARAXANTHINE.
- Mechanism
- Primary metabolite of caffeine, produced via CYP1A2 enzyme.
- Conversion Rate
- Approximately 84% of ingested caffeine converts to paraxanthine.
- Evidence Base
- Smaller and more recent than caffeine's literature.
- Note
- Mechanistically part of the same stimulant pathway as caffeine, despite being a distinct compound.
CATEGORY 3
Category 3: Functional Mushrooms
Lion's Mane, Cordyceps, and Reishi represent a mechanistically different approach. None act as stimulants. Each has its own, separate body of controlled human research.
STUDY CARD 01 — LION'S MANE.
- Design
- Randomized, double-blind, placebo-controlled, parallel-groups.
- Population
- 41 healthy adults, ages 18-45.
- Intervention
- 1.8g Hericium erinaceus daily.
- Result
- Significantly faster performance on the Stroop cognitive task following a single dose; trend toward reduced subjective stress after 28 days.
Docherty et al., 2023, Nutrients.
Lion's Mane is included in functional mushroom formulas for focus and cognitive support. In a randomized, double-blind, placebo-controlled trial of 41 healthy adults, a single dose produced significantly faster performance on a standard cognitive test (the Stroop task) compared with placebo, with a trend toward reduced subjective stress after 28 days of continued use.2 The trial's authors note the sample size was small and describe the findings as a promising early signal rather than a settled conclusion.
STUDY CARD 02 — CORDYCEPS.
- Design
- Randomized, double-blind, placebo-controlled.
- Population
- Healthy young adults.
- Intervention
- Cordyceps militaris-containing mushroom blend.
- Result
- Significant improvement in VO2 max after three weeks compared with placebo; separate crossover trial found improved reaction time following exhaustive exercise.
American Journal of Sports Science, 2018; PLOS ONE, 2026.
Cordyceps is included for energy, stamina, and blood flow support. A randomized, placebo-controlled trial found that three weeks of a Cordyceps-containing mushroom blend significantly improved VO2 max, a standard measure of the body's ability to use oxygen during exercise, compared with placebo.3 A separate randomized crossover trial found that Cordyceps militaris improved reaction time following exhaustive exercise compared with placebo.4 Both trials involved relatively small samples and measured physical or cognitive performance markers rather than subjective energy directly, so the research speaks most confidently to exercise- and blood-flow related outcomes.
STUDY CARD 03 — REISHI.
- Design
- Randomized, double-blind, placebo-controlled.
- Population
- 132 adults with chronic fatigue (neurasthenia).
- Intervention
- Ganoderma lucidum polysaccharide extract, 8 weeks.
- Result
- Improved fatigue scores and overall sense of well-being compared with placebo.
Tang et al., 2005, Journal of Medicinal Food.
Reishi is included for stress and wellness support. In a randomized, double-blind, placebo-controlled trial of 132 adults with chronic fatigue, an 8-week course of Reishi extract improved fatigue scores and overall sense of well-being compared with placebo.5 The study population had diagnosed chronic fatigue rather than being a general healthy population, which is worth noting when applying the finding more broadly.
What the Evidence Supports, And What It Doesn't
Q:
Does this mean functional mushrooms are proven to outperform caffeine or paraxanthine?
A: No. The three ingredient categories have not been tested head-to-head in a single controlled trial. What the research supports is narrower: each mushroom ingredient has its own independent evidence for the specific effect it's included for, through a mechanism that isn't stimulant-based.
Q:
Are these findings definitive?
A: No single study here is large enough to be called definitive. Sample sizes range from a few dozen to just over 100 participants, several trials measured acute or short-term effects rather than long-term use, and some findings (like Lion's Mane's stress trend) fell just short of standard statistical thresholds. They represent a genuine, growing evidence base, not a closed case.
Supported by the research
each mushroom ingredient has independent RCT evidence for its specific claimed effect; none function through a stimulant mechanism.
Not established by this research
no head-to-head trial comparing mushroom formulas against caffeine or paraxanthine directly; most individual trials are small and short in duration.
How This Applies to a Combined Formula
Flow, a breakthrough Texas-based company whose pouches have been used by more than 103,000 people to date, combines 100% organic fruiting body Lion's Mane, Cordyceps, and Reishi with TeaCrine® and methylcobalamin vitamin B12, delivered through the same gum-and-cheek absorption pathway used across the pouch category.
TeaCrine® supplies a premium, naturally derived, non-caffeine energy mechanism designed to work alongside a person's regular coffee or energy drink rather than replace it, without the jitters, crash, or dependency associated with caffeine. Methylcobalamin B12 is a highly bioavailable form of vitamin B12 that supports energy metabolism.
It's worth being precise about what this combination is and isn't. The formula has not itself been tested as a single combined product in a published clinical trial. What exists is independent research on each of its core ingredients, evaluated separately above. That's a meaningfully different evidentiary standard than a whole-product trial, and it's the same standard that applies to most multi-ingredient supplement formulas on the market, including the caffeine and paraxanthine products reviewed earlier.
FIVE INGREDIENTS. FIVE INDEPENDENT EVIDENCE BASES. ZERO STIMULANTS.
Not just harsh stimulants and flavoring in a pouch.
WHAT REAL-WORLD USAGE DATA ADDS
What real-world usage data adds, separate from the clinical research: in a 2026 post-purchase customer survey, 76 percent of Flow respondents reported quitting nicotine entirely or reducing their use by at least half, and 87 percent reported better energy throughout the day.6 This is self-reported survey data, not a controlled trial, and should be weighed accordingly alongside the ingredient-level research above.
Where This Leaves the Comparison
Caffeine and paraxanthine both work by acting on the same general stimulant pathway nicotine also acts on, just through different specific compounds. Functional mushrooms work through separate, non-stimulant mechanisms, each with its own independent research.
Neither approach is unproven. They're evaluated on different kinds of evidence, and it's worth knowing which kind you're actually getting when you read a pouch label.